CO-416 900-Unlocking FDA DCT Guidelines: What do They Mean for You and Your Team?
MAGI 2024: The Clinical Research Conference
Please let us know what you thought of this session.
1.
Please give an overall rating for this session.
1 Star = Poor | 4 Stars = Excellent
Poor
1 star
Below Average
2 stars
Above Average
3 stars
Excellent
4 stars
2.
Did the session meet the specified session description?
Yes
No
3.
The speaker was well prepared.
Strongly disagree
Disagree
Agree
Strongly agree
• Sandy Smith - SVP, Clinical Solutions & Strategic Partnering - WCG
Strongly disagree
Disagree
Agree
Strongly agree
• Melissa Bomben - Founder & CEO - True North Innovation Agency
Strongly disagree
Disagree
Agree
Strongly agree
• Catherine Gregor - Chief Clinical Trial Officer - Florence Healthcare
Strongly disagree
Disagree
Agree
Strongly agree
• Amanda Santimaw - Chief Research Officer - AARA Clinical Research
Strongly disagree
Disagree
Agree
Strongly agree
• Lovie Negrin - CEO - Randomize Now Research Centers
Strongly disagree
Disagree
Agree
Strongly agree
4.
The speaker communicated their content effectively.
Strongly disagree
Disagree
Agree
Strongly agree
• Sandy Smith - SVP, Clinical Solutions & Strategic Partnering - WCG
Strongly disagree
Disagree
Agree
Strongly agree
• Melissa Bomben - Founder & CEO - True North Innovation Agency
Strongly disagree
Disagree
Agree
Strongly agree
• Catherine Gregor - Chief Clinical Trial Officer - Florence Healthcare
Strongly disagree
Disagree
Agree
Strongly agree
• Amanda Santimaw - Chief Research Officer - AARA Clinical Research
Strongly disagree
Disagree
Agree
Strongly agree
• Lovie Negrin - CEO - Randomize Now Research Centers
Strongly disagree
Disagree
Agree
Strongly agree
5.
How can the organizers and speakers improve this session in the future?